Evidence map›Paper›PMID 38336830›Full record

ArticleScientific reports2024

Cross-regulation of Aps-promoters in Lacticaseibacillus paracasei by the PsdR response regulator in response to lantibiotics.

Qian Zhang, Manuel Zúñiga, Cristina Alcántara, Diana Wolf, Thorsten Mascher, Ainhoa Revilla-Guarinos

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Qian ZhangChair of General Microbiology, Technische Universität Dresden, 01217, Dresden, Germany.
Manuel ZúñigaDepartamento de Biotecnología, Instituto de Agroquímica y Tecnología de Alimentos (IATA), Consejo Superior de Investigaciones Científicas (CSIC), 46980, Paterna, Valencia, Spain.
Cristina AlcántaraDepartamento de Biotecnología, Instituto de Agroquímica y Tecnología de Alimentos (IATA), Consejo Superior de Investigaciones Científicas (CSIC), 46980, Paterna, Valencia, Spain.
Diana WolfChair of General Microbiology, Technische Universität Dresden, 01217, Dresden, Germany.
Thorsten MascherChair of General Microbiology, Technische Universität Dresden, 01217, Dresden, Germany. thorsten.mascher@tu-dresden.de.ORCID 0000-0002-6300-5541
Ainhoa Revilla-GuarinosChair of General Microbiology, Technische Universität Dresden, 01217, Dresden, Germany. ainhoa.revilla@fisabio.es.ORCID 0000-0002-9894-3538
Technische Universität Dresden · DEConsejo Superior de Investigaciones Científicas · ESFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The PsdRSAB and ApsRSAB detoxification modules, together with the antimicrobial peptides (AMPs)-resistance determinants Dlt system and MprF protein, play major roles in the response to AMPs in Lacticaseibacillus paracasei BL23. Sensitivity assays with a collection of mutants showed that the PsdAB ABC transporter and the Dlt system are the main subtilin resistance determinants. Quantification of the transcriptional response to subtilin indicate that this response is exclusively regulated by the two paralogous systems PsdRSAB and ApsRSAB. Remarkably, a cross-regulation of the derAB, mprF and dlt-operon genes-usually under control of ApsR-by PsdR in response to subtilin was unveiled. The high similarity of the predicted structures of both response regulators (RR), and of the RR-binding sites support this possibility, which we experimentally verified by protein-DNA binding studies. ApsR-P shows a preferential binding in the order P

Indexed as

BacteriocinsLacticaseibacillus paracaseiBacterial ProteinsGene Expression Regulation, BacterialOperonPromoter Regions, GeneticBacterial ProteinsBacteriocins

Identifiers

PMID38336830
PMCPMC10858260
OpenAlexW4391685740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.